NCT00840398View on ClinicalTrials.gov

Buspirone Hydrochloride 30mg Tablets, Non-Fasting

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

December 31, 2001

Study Completion Date

December 31, 2001

Conditions
Healthy
Interventions
DRUG

BUSPAR® 30 mg Tablet

1 x 30 mg, single-dose fed

DRUG

Buspirone Hydrochloride 30 mg Tablet

1 x 30 mg, single-dose fed

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00840398 - Buspirone Hydrochloride 30mg Tablets, Non-Fasting | Biotech Hunter | Biotech Hunter